Short-term efficacy and safety of Insulin Degludec in Japanese patiets with type 1 diabetes: a pilot study.

Short-term efficacy and safety of Insulin Degludec in Japanese patiets with type 1 diabetes: a pilot study. - Efficacy and safety of Insulin Degludec in Japanese patiets with type 1 diabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017474

Enrollment

Registered

2015-05-08

Start date

2014-01-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 diabetes

Interventions

Insulin Degludec

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Type 1 diabetes 2.Patients were not treated with insulin degludec previously. 3.Patients were agreed to participate in this study with written informed consent.

Exclusion criteria

Exclusion criteria: Patients were free of severe infections, seriously wounded, alcohol abuser, malnutrition or staving, pregnant women and women suspected of being pregnant, with low compliance.

Design outcomes

Primary

Measure	Time frame
Comparison of blood glucose variability at night by CGM	—

Countries

Japan

Contacts

Public ContactUdai Nakamura

Kyushu University Hospital Department of Medicine and Clinical Science

uday@intmed2.med.kyushu-u.ac.jp092-642-5256

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026